N-Power Medicine, Inc.

N-Power Medicine is developing a radically faster, smarter paradigm for drug development that enables biopharma to move beyond traditional randomized clinical trials.

Through a network of community oncology practices and proprietary infrastructure, N-Power has built a next-generation platform where every cancer patient can participate in research, either as a trial participant or as part of a regulatory-grade Prospective External Control Arm (ProECA).

Powered by the Kaleido™ Registry and ProECA platform, N-Power’s model reduces reliance on randomization, cuts years off development timelines, and saves hundreds of millions of dollars per program.

N-Power is expanding access to clinical trials and redefining what’s possible in cancer drug development.